Equity Overview
Price & Market Data
Price: $2.97
Daily Change: +$0.14 / 4.71%
Range: $2.97 - $2.97
Market Cap: $38,234,432
Volume: 1,040
Performance Metrics
1 Week: -2.08%
1 Month: 45.13%
3 Months: -40.92%
6 Months: -80.01%
1 Year: -83.05%
YTD: -67.09%
Company Details
Employees: 46
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.